RecruitingNCT07158879

Skin Reactions Related to Thoracic Implantable Chamber Dressings

Sponsor

Institut Curie

Enrollment

500 participants

Start Date

Jun 10, 2025

Study Type

OBSERVATIONAL

Conditions

Skin Diseases

Summary

Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria3

Patients over 18 years of age
New chemotherapy patients (1st line of treatment only)
Thoracic PAC

Exclusion Criteria9

PICC Line and femoral PAC;
Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp);
Disunion requiring treatment
Patients treated for hematological cancer;
Persons deprived of their liberty or under guardianship (including curatorship);
Adults under court protection;
Inability to participate in the study for geographical, social or psychological reasons.
No inclusion of persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.).
Opposition to data use